COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Announces Upcoming Conference Participation

21/02/2018 - 14:45

NEW YORK and CLEVELAND, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

21/02/2018 - 14:31

FIT Biotech Oy Company release February 21, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences

21/02/2018 - 14:30

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee

21/02/2018 - 14:30

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]

Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results

21/02/2018 - 14:30

SOLANA BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will [...]

Tower One Announces Final Approval and Implementation of Warrant Incentive Program and Warrant Listing on Canadian Securities Exchange

21/02/2018 - 14:17

VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company ”) announces, further to its news release dated January 9, [...]

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences

21/02/2018 - 14:05

TUSTIN, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]

Allscripts to present at 2018 RBC Capital Markets Global Healthcare Conference

21/02/2018 - 14:01

CHICAGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) today announced that certain members of its management team will present at the 2018 RBC Capital Markets Global Healthcare Conference, to be held at [...]

Premier Biomedical Inc., CEO William Hartman Returns to Uptick Newswire’s “Stock Day” with Everett Jolly

21/02/2018 - 14:00

PHOENIX, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC:BIEI) President & CEO, William A. Hartman today reviewed operational accomplishments of 2017 and expectations for 2018 in an interview on [...]

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

21/02/2018 - 14:00

--Ended 2017 with a healthy cash position of $380M -- --Recently announced FDA approval and launch of Glatopa ® 40 mg-- CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ) [...]

Dr. Eugene Sun Appointed to Novan Board of Directors

21/02/2018 - 14:00

Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEO Will provide expert perspective on the clinical application of the underlying nitric oxide science Will chair [...]

Amicus Therapeutics to Announce Full-Year 2017 Financial Results on February 28, 2018

21/02/2018 - 13:30

CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced a conference call and live audio webcast on Wednesday, February 28, 2018 at 8:30 a.m. ET to discuss financial results [...]

TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase 1 First-in-Human Trial of Umbralisib in The Lancet Oncology

21/02/2018 - 13:30

Umbralisib is structurally distinct from other PI3K delta inhibitors with greater selectivity to PI3K delta and unique complementary inhibition of casein kinase-1 (CK1) epsilon Single agent umbralisib was well tolerated [...]

Recro Pharma to Host Analyst and Investor Day on February 28, 2018

21/02/2018 - 13:00

MALVERN, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, M.D. to its Board of Directors

21/02/2018 - 13:00

HOUSTON, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2017 Financial Results Conference Call

21/02/2018 - 13:00

SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the Company's fourth [...]

FibroGen to Report Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 27, 2018

21/02/2018 - 13:00

SAN FRANCISCO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that it will report fourth quarter and full year 2017 financial results on [...]

Update: Natus to Present at Raymond James 39th Annual Institutional Investors Conference

21/02/2018 - 13:00

PLEASANTON, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will present at the Raymond [...]

Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations

21/02/2018 - 13:00

BERKELEY HEIGHTS, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]